
Twist Bioscience Corporation TWST
$ 81.92
7.55%
Quarterly report 2025-Q4
added 02-02-2026
Twist Bioscience Corporation DSO Ratio 2011-2026 | TWST
Annual DSO Ratio Twist Bioscience Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 44.5 | 46 | 62.8 | 61.7 | 75.7 | 77.9 | 81.2 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 81.2 | 44.5 | 64.3 |
Quarterly DSO Ratio Twist Bioscience Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 47.1 | - | 47.4 | 43.9 | 38.2 | - | 38.1 | 43.2 | 50.7 | - | 65 | 70.2 | 71.3 | 25.4 | 61.9 | 64.2 | 66.7 | 27.4 | 73.8 | 79 | 84 | 41.7 | 113 | 63.9 | 66.9 | 28.6 | 81.2 | 50.7 | 49.2 | 29.1 | 75.6 | 21.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 113 | 21.5 | 55.8 |
DSO Ratio of other stocks in the Diagnostics research industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 201.41 | -0.81 % | $ 22.4 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
94.7 | $ 4.05 | -5.71 % | $ 5.39 M | ||
|
Fulgent Genetics
FLGT
|
87 | $ 18.82 | 0.74 % | $ 579 M | ||
|
Castle Biosciences
CSTL
|
50.2 | $ 20.98 | 1.35 % | $ 608 M | ||
|
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
72.7 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
Interpace Biosciences
IDXG
|
66.9 | $ 1.64 | 2.19 % | $ 7.26 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
46.1 | $ 132.35 | 0.55 % | $ 16.6 B | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 23.83 | 3.74 % | $ 1.27 B | ||
|
Illumina
ILMN
|
66.8 | $ 166.13 | 3.21 % | $ 25.8 B | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
ICON Public Limited Company
ICLR
|
63.4 | $ 147.98 | 1.23 % | $ 11.6 B | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 161.11 | 2.62 % | $ 23.9 B | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
NeoGenomics
NEO
|
77.7 | $ 11.21 | 0.54 % | $ 1.44 B | ||
|
National Research Corporation
NRC
|
29.4 | $ 18.77 | -0.11 % | $ 420 M | ||
|
Natera
NTRA
|
48.3 | $ 216.16 | 1.93 % | $ 29.6 B | ||
|
Lantheus Holdings
LNTH
|
80.5 | $ 104.54 | 0.02 % | $ 7.06 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 190.24 | 1.46 % | $ 9.43 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
Pacific Biosciences of California
PACB
|
71.8 | $ 1.39 | 5.81 % | $ 417 M | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 468.22 | 0.19 % | $ 13.5 B | ||
|
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
52.3 | $ 4.32 | -0.23 % | $ 400 M | ||
|
Personalis
PSNL
|
63.8 | $ 10.25 | 6.88 % | $ 915 M | ||
|
Senseonics Holdings
SENS
|
1.04 | $ 7.31 | 1.74 % | $ 305 M | ||
|
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
27 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
57.7 | $ 2.01 | -1.95 % | $ 4.62 M | ||
|
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 264.57 | -0.6 % | $ 22 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 474.8 | 1.26 % | $ 179 B | ||
|
Trinity Biotech plc
TRIB
|
87.2 | $ 0.67 | 2.52 % | $ 241 M | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
66.6 | $ 9.22 | 1.26 % | $ 2 B | ||
|
Invitae Corporation
NVTA
|
242 | - | - | $ 21.2 M |